Cyclosporin-A Augments Respiratory Burst of Whole Blood Phagocytes in Pregnant Rats

REFERENCES

• Luppi P. How immune mechanisms are affected by pregnancy. Vaccine 2003; 21: 3352–3357
   PubMed Web of Science ®Google Scholar
• Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanism: the production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Investig 1973; 52: 741–744
   PubMed Web of Science ®Google Scholar
• Shibuya T., Izuchi K., Kuroiwa A., Okabe N., Shirakawa K. Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes. Am. J. Rep. Immun. Microbiol 1987; 15: 19–23
   PubMed Web of Science ®Google Scholar
• Selvaraj R.J., Sbarra A.J., Thomas G.B., Cetrulo C.L., Mitchell G.W., Jr. A microtechnique for studying chemiluninescence response of phagocytes using whole blood and its application to the evaluation of phagocytes in pregnancy. J. Reticuloendothel. Soc 1982; 31: 3–16
   PubMedGoogle Scholar
• Imai N., Watanabe R., Fujiwara H., Ito M., Nakamura A. Successful treatment of impetigo herpetiformis with oral cyclosporine during pregnancy. Arch. Dermatol 2002; 138: 128–129
   PubMedGoogle Scholar
• Petri M. Immunosuppressive drug use in pregnancy. Autoimmunity 2003; 36: 51–56
   PubMed Web of Science ®Google Scholar
• Christopher V., Al-Chalabi T., Richardson P.D., et al. Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients. Liver Transpl 2006; 12: 1138–1143
   PubMed Web of Science ®Google Scholar
• Keller F., Griesshammer M., Haussler U., Paulus W., Schwarz A. Pregnancy and renal failure: the case for application of dosage guidelines. Drugs 2001; 61: 1901–1920
   PubMed Web of Science ®Google Scholar
• Shevach E.M. The effects of cyclosporin A on the immune system. Ann. Rev. Immunol 1985; 3: 397–423
   PubMed Web of Science ®Google Scholar
• Kharazmi A., Svenson M., Nielsen H., Birgens H.S. Effect of cyclosporin A on human neutrophil and monocyte function. Scand. J. Immunol 1985; 21: 585–591
   PubMed Web of Science ®Google Scholar
• Lilius E., Waris M. A very sensitive and rapid chemiluminescence method for the measurement of phagocytosis. Analytical Applications of Bioluminescence and Chemiluminescence. Academic Press. 1984; 401–404
   Google Scholar
• Thomson A.W. The effect of cyclosporin A on non-T cell components of the immune system. J. Autoimmun 1992; 5: 167–176
   PubMed Web of Science ®Google Scholar
• Sacks G.P., Tudena K., Sargent I.L., Redman C.W.G. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol 1998; 179: 80–86
   PubMed Web of Science ®Google Scholar
• Hrycek A., Szoltysik I. Evaluation of phagocytic activity of peripheral blood neutrophils in patients after kidney transplantation treated with cyclosporin and prednisone or with azathioprine with prednisone. Acta Haematol. Pol 1992; 23: 253–258
   PubMedGoogle Scholar
• Lun M.T., Gaeta A., Brenciaglia M.I., et al. Monocytes phagocytic activity in cyclosprin treated patients. Microbiologica 1985; 8: 277–282
   PubMed Web of Science ®Google Scholar
• Chen S.Y., Liu S.T., Hou L.B., Chen Z.L. Effects of ciclosporin on whole blood chemiluminescence of renal transplant patients. Zhongguo Yao Li Xue Bao 1998; 19: 372–375
   PubMed Web of Science ®Google Scholar
• Schopf R.E., Hocher J., Rehder M., Farber L., Morsches B. Etretinate or cyclosporin A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis. Arch. Dermatol. Res 1992; 284: 227–231
   PubMed Web of Science ®Google Scholar
• Shibuya T., Izuchi K., Kuroiwa A., Harada H., Kumamoto A., Shirakawa K. Study on nonspecific immunity in pregnant women: II. Effect of hormones on chemiluminescence response of peripheral blood phagocytes. Am. J. Reprod. Immunol 1991; 26: 76–81
   PubMed Web of Science ®Google Scholar
• Rezzani R., Rodella L.F., Tengattini S., et al. Protective role of polyphenols in cyclosporine A-induced nephrotoxicity during rat pregnancy. J. Histochem. Cytochem 2006; 54: 923–932
   PubMed Web of Science ®Google Scholar
• Tendron A., Decramer S., Justrabo E., Gouyon J.B., Semama D.S., Gilbert T. Cyclosporin A administration during pregnancy induces a permanent nephron deficit in young rabbits. J. Am. Soc. Nephrol 2003; 14: 3188–3196
   PubMed Web of Science ®Google Scholar
• Hussain I., Piepenbrink M.S., Fitch K.J., Marsh J.A., Dietert R.R. Developmental immunotoxicity of cyclosporin-A in rats: age-associated differential effects. Toxicology 2005; 206: 273–284
   PubMed Web of Science ®Google Scholar
• Hold P.M., Wong C.F., Dhanda R.K., Walkinshaw S.A., Bakran A. Successful renal transplantation during pregnancy. Am. J. Transplant 2005; 5: 2315–2317
   PubMed Web of Science ®Google Scholar
• Al-Khader A.A., Al-Ghamdi B.N, et al. Pregnancies in renal transplant recipients--with a focus on the maternal issues. Ann. Transplant 2004; 9: 62–64
   PubMedGoogle Scholar
• Sgro M.D., Barozzino T., Mirghani H.M., et al. Pregnancy outcome post renal transplantation. Teratology 2002; 65: 5–9
   PubMedGoogle Scholar
• Oliveira L.G., Sass N., Sato J.L., Ozaki K.S., Medina Pestana J.O. Pregnancy after renal transplantation—a five-yr single-center experience. Clin. Transplant 2007; 21: 301–304
   PubMed Web of Science ®Google Scholar
• Day C., Hewins P., Sheikh L., Kilby M., McPake D., Lipkin G. Cholestasis in pregnancy associated with ciclosporin therapy in renal transplant recipients. Transpl. Int 2006; 19: 1026–1029
   PubMed Web of Science ®Google Scholar
• Czajkowski K., Wojcicka-Bentyn J., Sienko J., et al. Renal function and lipid metabolism in pregnant renal transplant recipients. Eur. J. Obstet. Gynecol. Reprod. Biol 2004; 114: 155–161
   PubMed Web of Science ®Google Scholar